Remember, they had an 'expected' payout of NZ$90-96m. They've chosen to pay NZ$100m.
However, the payout amounts were variable based on FY21/22 performance:
They've brought forward the payout and effectively offered 7 times FY21 EBIT, instead of 6.7-7.2 times FY22 EBIT.
I think that's quite prudent, especially given the growth rates.
If you believe earnings will grow, you've effectively avoided paying extra on the performance uplift, as you have for the 40% that could be deferred to FY23.
This allows the vendors to leave earlier than planned, and ADH to improve the business without an additional tax on earnings increases.
Win-win as far as I can tell.
- Forums
- ASX - By Stock
- ADH
- Ann: Early settlement of deferred Mocka consideration
Ann: Early settlement of deferred Mocka consideration, page-9
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.50 |
Change
-0.070(2.72%) |
Mkt cap ! $439.5M |
Open | High | Low | Value | Volume |
$2.56 | $2.56 | $2.42 | $1.786M | 721.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 14549 | $2.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.50 | 3416 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 14549 | 2.460 |
1 | 2000 | 2.450 |
4 | 19520 | 2.430 |
2 | 3833 | 2.410 |
1 | 3000 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.500 | 3416 | 1 |
2.510 | 2406 | 1 |
2.520 | 6920 | 2 |
2.530 | 3595 | 2 |
2.540 | 2000 | 1 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
ADH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online